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Background: Solena heterophylla Lour. has traditionally been used in the management of diseases pertaining to
gastrointestinal, respiratory and vascular system and present study was undertaken to validate its traditional uses.
Methods: The aqueous ethanolic extract of Solena heterophylla Lour (Sh.Cr) was tested in-vitro on isolated rabbit
jejunum, tracheal and aorta preparations. The responses of tissues were recorded using isotonic transducers
coupled with PowerLab data acquisition system.
Results: The aqueous ethanolic extract of Solena heterophylla Lour (Sh.Cr) (0.03-1.0 mg/ml) on application to
spontaneous contractions in isolated rabbit jejunum preparation exerted relaxant effect through decrease in
magnitude and frequency of contractions, caused relaxation of K+(80 mM)-induced contractions and shifted the
Ca2+ concentration response curves toward right in isolated rabbit jejunum preparations in a manner similar to
verapamil (a standard Ca2+ channel blocker), thus confirming its Ca2+ channel blocking activity. The Sh.Cr also
caused relaxation of carbachol (1 μM)- and K+(80 mM)-induced contractions in isolated rabbit tracheal preparations
in a manner comparable to dicyclomine.
Conclusions: The observed relaxant effect may be outcome of anti-muscarinic and Ca2+ channel blocking activities.
The Sh.Cr (0.03-1.0 mg/ml) against phenyephrine (1 μM)- and K+(80 mM)-induced contractions in isolated rabbit
aortic preparations exerted a relaxant effect, possibly through Ca2+ channel blocking activity. These findings
provide a rationale for the folkloric uses of the plant in the management of ailments pertaining to gastrointestinal,
respiratory and vascular system.
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Solena heterophylla Lour. (Cucurbitaceae) is a climber
plant, distributed widely in India, Pakistan, Afghanistan,
Indonesia, Malaysia, Myanmar, Nepal, China, Thailand
and Vietnam [1-3]. The plant grows in mixed forests,
thickets grasslands, roadsides, and mountain slopes at
an altitude of 600–2600 m [4]. The roots are fusiform,
about 1.5-2 cm in diameter. The stem and branches are
glabrous, petiole are slender, 4–10 mm, puberulent at* Correspondence: ahirzia@gmail.com; defeo@unisa.it
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unless otherwise stated.first but subsequently glabrescent. The leaf blade are
variable, ovate, oblong, ovate-triangular, or hastate, un-
divided or 3-5-lobed, leathery; lobes oblong-lanceolate,
lanceolate, or triangular, 8–12 × 1–5 cm2, abaxially
densely setose or almost glabrous, adaxially densely se-
tose or scabrous, base cordate, margin entire or dentate,
apex obtuse or acuminate. Tendrils are slender. The
male flowers are umbellate or sub-umbellate; peduncle
very short, apically 10-20-flowered; pedicels 2–8 mm;
calyx tube 3–5 mm, 3 mm in diameter; segments subu-
late, 0.2-0.4 mm; corolla yellow or yellow-white; seg-
ments triangular, 1–1.5 mm, apex obtuse or acute;
filaments filiform, about 3 mm; anther cells curved or
conduplicate, puberulent. The female flowers are usuallyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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corolla are similar to male flowers; ovary ovoid, 2.5-
3.5 × 2–3 mm2; stigmas 3. The fruits are red-brown,
broadly ovoid, oblong, or sub-globose, 2–6 × 2–5 cm2.
The seeds are gray-white or gray-brown, sub-orbicular
or obovate, 5–7 × 5–6.5 mm2, smooth or slightly tuber-
culate. Flowering occurs in May-August and fruiting in
June-November [5].
Various parts of this plant possess anti-malarial, anti-
diabetic, analgesic, sedative and purgative properties and
used to treat toothache, rheumatism and respiratory
disorders [6,7]. It is believed to possess invigorating and
stimulant properties. The fruits have traditionally been
used in the management of common cold, child pneu-
monia, throat pain and fever; the leaves are applied over
inflamed skin, whereas root juice has been used to treat
dysuria and spermatorrhoea [4,8]. Phytochemical investi-
gations revealed the presence of behemic acid, columbin
and lignoceric acid as plant constituents [4,9]. Scientific
investigations on plant extract revealed its hepatoprotec-
tive potential, while coumarin and flavonoids isolated
from plant were found to inhibit platelet aggregation
[10-12]. Moreover, recent study has reported in-vitro
and in-vivo antioxidant activity of methanolic extract of
Solena whole plant [13] as well as methanolic extract of
leaf and stem of S. heterophylla [14]. S. heterophylla
has traditionally been used for the management of
gastrointestinal, respiratory and cardiovascular ailments
[15,16], but no study exists on validation of these activ-
ities. As part of series of experiments in our laboratory
on validating tagged biological and physiological activ-
ities of medicinal plants [17-22], the current study was
designed to investigate and validate the therapeutic




The aerial parts of Solena heterophylla were collected
from hilly areas of Nathia Gali (Abbottabad), Pakistan in
August 2011. The plant was authenticated by the expert
taxonomist Prof. Dr. Altaf Ahmad Dasti, Institute of
Pure and Applied Biology, Bahauddin Zakariya University,
Multan, Pakistan and a voucher specimen in preserved
in the same University. The plant material was ren-
dered free of foreign contamination by manual picking
and allowed to be dried in shade. The dried herbal ma-
terial was grinded into coarse powder by means of a
herbal grinder and was subjected to maceration by
soaking (1000 g) in aqeous-ethanolic (70%) mixture in
amber colour glass container at room temperature for
7 days with occasional shaking. The material was
passed through a muslin cloth and fluid obtained was
filtered through Whatmann-1 filter paper. The filtratewas evaporated on a rotary evaporator (Büchi R-200
Switzerland) attached with a vacuum pump (Büchi
Vac V-500) and re-circulating chiller (B-740) at 37°C
under reduced pressure to a thick dark green paste
of semi solid consistency, with an approximate yield
of 23%. The extract was stored in air tight jar and all
the dilutions were made fresh on the day of experi-
ment [23,24].
Chemicals
Acetylcholine chloride, carbachol, potassium chloride,
verapamil hydrochloride, phenylephrine, magnesium
chloride, ethylene tetra-acetic acid (EDTA) were pur-
chased from Sigma Chemicals Co. (St Louis, MO, USA).
Calcium chloride, glucose, magnesium sulphate, potas-
sium dihydrogen phosphate, sodium bicarbonate, sodium
dihydrogen phosphate and methanol were obtained from
Merck (Darmstadt, Germany). Ammonium hydroxide, so-
dium chloride, and sodium hydroxide were purchased
from BDH Laboratory supplies (Poole, England). The che-
micals used in these experiments were of highest purity
and reagent analytical grade. Stock solutions and subse-
quent dilutions were made in distilled water on the day of
experiment. The drugs were made soluble in vehicles
which were without any effect on tissues in control
experiments.
Experimental animals and housing conditions
Animals (♂/♀) used in this study were local strain rab-
bits (1.0-1.8 kg). These were housed under controlled
environmental condition (23–25°C) at the animal house
of Faculty of Pharmacy, Bahauddin Zakariya University,
Multan. The animals were provided with standard food
and tap water ad libitum. The animals were deprived
of food 24 hr prior to the experiments but were
given free access to water. Rabbits were sacrificed follow-
ing a blow on back of head to be used for in vitro studies.
All the experiments performed complied with the
rulings of Institute of Laboratory Animal Resources,
Commission on Life Sciences [25]. The experimental
protocols regarding current study were submitted to
and approved by the ethical committee meeting held
on 16-02-2011 via Notification Number EC/04/2011
dated of the Department of Pharmacy, Bahauddin Zakariya
University, Multan.
In vitro experiments
The experiments on isolated tissues were performed by
procedures previously described [17-21]. Briefly, we used
freshly prepared jejunum, tracheal and aortic tissue seg-
ments from the rabbit and maintained adequately in the
respective buffer solutions. The detailed elaboration of
each tissue extraction procedure is described below
under the respective heading of tissue of interest.
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The crude ethanolic extract of S. heterophylla (Sh.Cr)
was tested for the possible presence of either spasmo-
lytic or spasmogenic activity by using isolated rabbit
jejunum preparations. Isolated rabbit jejunum segments
of approximately 2 cm in length were suspended in iso-
lated tissue baths containing Tyrode’s solution, at 37°C,
aerated with carbogen (95% O2 and 5% CO2). The com-
position of the Tyrode’s solution (mM) was: KCl (2.68),
NaCl (136.9), MgCl2 (1.05), NaHCO3 (11.90), NaH2PO4
(0.42), CaCl2 (1.8) and glucose (5.55). A preload of 1 gm
was applied and intestinal responses were recorded
through an isotonic transducer by Power Lab Data
Acquisition System (AD Instruments, Sydney, Australia)
attached to a computer installed with a Lab Chart
Software (Version 6). The tissues were allowed to equili-
brate for at least 30 min prior to the addition of any
drug. Isolated rabbit jejunum preparations exhibit spon-
taneous rhythmic contractions and allow testing of the
antispasmodic (relaxant) effect without application of an
agonist [26]. The observed response of the test material
was quantified by the application of doses in a cumula-
tive fashion. The relaxant effects on the part of the test
substances were taken as the percent change in spontan-
eous contractions of the preparation recorded immedi-
ately before the addition of test substances.
The possible mechanism of the relaxant activity of the
test materials were investigated through the relaxation of
the observed sustained spasmodic contractions following
the exposure to high concentration of K+(80 mM) [27].
The test materials were applied in a cumulative manner
to the sustained contractions to achieve concentration-
dependent inhibitory responses [28]. The observed relaxant
effect of the test materials on K+ (80 mM)-induced con-
traction was expressed as percent of the control contractile
response.
Calcium channel blocking effect of the test substances
were confirmed by the method described by Gilani et al.
[26]. The isolated rabbit jejunum preparations were
allowed to stabilize in normal Tyrode’s solution, which
were subsequently replaced for 30 min with Ca2+-free
Tyrode’s solution to which EDTA (0.1 mM) was added
in order to remove calcium from the tissues. This bath
solution was further replaced with K+-rich and Ca2+-free
Tyrode’s solution, having the following composition (mM):
KCl (50), NaCl (91.04), MgCl2 (1.05), NaHCO3 (11.90),
NaH2PO4 (0.42), glucose (5.55) and EDTA (0.1). Subse-
quent to an incubation period of 30 min., cumulative
Ca2+ concentrations were applied to the tissue bath to ob-
tain control calcium dose–response curves (DRCs). On
achievement of the super-imposable control calcium dose–
response curves (usually after two cycles), the tissues were
then washed and allowed to equilibrated with the plant ex-
tract for 1 hr and then the concentration response curvesof Ca2+ were recorded and compared to the control curves.
The DRCs of Ca2+ were recorded in the presence of differ-
ent concentrations of the plant extracts in tissue bath.
Isolated rabbit tracheal preparations
The rabbit tracheas were dissected out and kept in Krebs
solution with the following composition (mM): NaCl
(118.2), NaHCO3 (25.0), CaCl2 (2.5), KCl (4.7), KH2PO4
(1.3), MgSO4 (1.2) and glucose (11.7). The trachea was
cleaned free from the surrounding fatty tissues and rings
of 2–3 mm width containing 2–3 cartilages were pre-
pared. Each ring was opened by a longitudinal incision
on the ventral side opposite to the smooth muscles layer
to form a strip with smooth muscles layer in middle and
cartilages on both sides. These tracheal preparations
were mounted in 20 ml organ bath containing Krebs
solution being maintained at 37°C and aerated with car-
bogen. A preload tension of 1 g was applied and tissue
preparations were allowed to be equilibrated for 1 hour
prior to any challenge by the drug. Tissue preparations
were stabilized by repeated applications of carbachol
(1 μM) until constant responses were recorded. The car-
bachol (1 μM)- and high K+(80 mM)-induced sustained
contractions were subsequently used for testing of differ-
ent doses of the test material in a cumulative fashions.
The isometric responses were recorded through a Power
Lab Data Acquisition System (AD Instruments, Sydney,
Australia) attached to a computer installed with a Lab
Chart Software (Version 6). The standard drug with Ca2+
channel blocking effect (verapamil) was tested on high
K+(80 mM)- and carbachol- induced spastic contractions
in order to confirm the possible mechanism of action.
Isolated rabbit aorta preparation
The effect of Sh.Cr on systemic vascular resistance was
assessed on isolated rabbit aorta preparations. Rabbits of
either sex were sacrificed by a blow on the back of head
and descending thoracic aorta was dissected out and
kept in the normal Krebs solution having composition as
above described. It was then cut vertically in 2–3 mm
width segments. Each isolated tissue segment was then
hung in a tissue organ bath (Radnoti) containing Kreb’s
solution aerated with carbogen (95% oxygen and 5% car-
bon dioxide) at 37°C. A pre-load of 2 g was applied to
each preparation and allowed to equilibrate for a period
of 1 hr. After equilibration, tissue was stabilized by re-
peated exposure to K+ (80 mM) or phenylephrine
(1 μM) depending upon the protocol of the experiment.
The vasorelaxant/vasoconstrictive effects of the test sub-
stances were studied by addition in tissue organ baths
containing pre-stabilized tissue in a cumulative manner.
Changes in isometric tension of aortic rings were
obtained via fa orce-displacement transducer (Model
FORT100, WPI, USA) coupled to a Power Lab data
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and a computer running Lab Chart software (version 6).
Statistical analysis
Data are expressed as mean ± S.E.M. (n = 5 of individual
experiments) and median effective concentration (EC50)
are given with 95% confidence intervals (CI) and the
logarithmic dose response curves of different treat-
ments were then plotted using the Computer soft-
ware “Graphpad Prism” (Graph Pad Software, San Diego,
CA, USA).
Results
Effect of Sh.Cr on isolated rabbit jejunum preparations
The aqueous ethanolic extract of Solena heterophylla
Sh.Cr when applied to spontaneous contractions in isolated
rabbit jejunum preparations, exerted a relaxant effect in
tissue bath concentration-dependent manner, in concen-
tration range of 0.03-1.0 mg/ml, with an EC50 value of
0.07002 mg/ml (95% CI: 0.08482-0.1644 mg/ml, n = 5)
(Figures 1 and 2). The application of Sh.Cr to K+ (25 mM)-
induced spastic contractions in isolated rabbit jejunum
preparations, resulted in minor relaxant response
with an EC50 value of 0.3226 mg/ml (95% CI: 0.01782-
0.3679 mg/ml, n = 5) (Figure 2a and c), whereas the
application to K+ (80 mM)-induced spastic contrac-
tions caused a complete relaxation, with an EC50
value of 0.06824 mg/ml (95% CI: 0.1459-0.2781, n = 5)
(Figure 2b and c). Similarly, verapamil also relaxed the
spontaneous and K+ (80 mM)-induced contractions in iso-
lated rabbit jejunum preparations, with respective EC50
values of 0.795 μM (95% C.I: 0.588- 1.105 μM; n = 5) and
0.4511 μM (95% C.I: 0.2944-0.6787 μM; n = 5) (Figure 2d).
Moreover, the pretreatment of isolated rabbit jejunum
preparations with Sh.Cr (0.1-1.0 mg/ml) caused a right-
ward shift of Ca2+ concentration response curves in a man-
ner similar to that produced by verapamil (Figure 3).
Effect of Sh.Cr on isolated rabbit tracheal preparations
The application of Sh.Cr on isolated rabbit tracheal
preparations did not produce any response (not shown),0.03 0.01 0.1
(b)
(a)
Figure 1 Tracings showing (a) the spontaneous contraction of isolated rabbi
Solena heterophylla (Sh.Cr). Plant extract was added in cumulative manner andhowever, it exerted a relaxant effect on the carbachol
(CCh; 1 μM) and K+ (80 mM) induced contractions
(Figure 4a,b and c) with respective EC50 values of
0.06550 mg/ml (95% CI: 0.09267- 0.1721 mg/ml, n = 5)
and 0.06926 mg/ml (95% CI: 0.1422-0.2761 mg/ml, n = 5).
The comparison of the above mentioned values shows that
EC50 of Sh.Cr for CCh-induced contractions is numerically
minor if compared to EC50 value of Sh.Cr for K
+ (80 mM)-
induced contractions in isolated rabbit tracheal prepara-
tions. For this reason, it is possible that some components
of Sh.Cr exerted their relaxant effect through the blockade
of muscarinic receptors, whereas remaining components
may contribute to the relaxant effect through th eblockade
of Ca2+ channels in a manner comparable to dicyclomine,
which caused relaxation of CCh and K+ (80 mM) –induced
contractions with EC50 values of 0.08764 μM (95% CI:
0.05573-0.1317; n = 5) and 0.08846 μM (95% CI: 0.04268-
0.09845; n = 5), respectively (Figure 4).
Effect of Sh.Cr on isolated rabbit aorta preparations
Sh.Cr did not exert any effect on isolated rabbit aorta
preparation in isolated tissue bath concentration range
of 0.01-5 mg/ml (Figure 5a). However, it relaxed phenyl-
ephrine (1 μM) and K+ (80 mM)-induced contractions
with respective EC50 values of 0.05571 mg/ml (95% CI:
0.04482-0.07642 mg/ml, n = 5) and 0.04955 mg/ml (95%
CI: 0.09620-0.1537, n = 5) (Figure 5b, c and d). As the EC50
value of Sh.Cr for phenylephrine-induced contractions was
found to be high in comparison with the EC50 value of
Sh.Cr for K+(80 mM)-induced contractions, it is possible
that the relaxant effect of Sh.Cr on phenylephrine- and
K+(80 mM)-induced contractions may be mediated
through the blockade of Ca2+ channels in a manner similar
to verapamil, exerting ra elaxant effect on phenyleprine-
and K+(80 mM)-induced contractions with respective EC50
values of of 0.87 μM (95% CI:0.037-5.62; n = 5) and
0.47 μM (95% CI: 0.033-2.11; n = 5) (Figure 5e).
Discussion
Cardiovascular, respiratory and gastrointestinal problems
are some of most common ailments that people face1.0  mg/ml0.3 (Sh.Cr)
Control
t jejunum and (b) the spasmolytic effect of the crude ethanol extract of
values listed were the final tissue bath concentrations, (n = 5).
Figure 2 Concentration dependent effect of (a,b,c) the ethanol extract of Solena heterophylla (Sh.Cr) and (d) verapamil on spontaneous, low K+
(25 mM) and high K + (80 mM)-induced contractions in isolated rabbit jejunum preparations. Values are the mean ± SEM, n = 5.



































Figure 3 Effect of (a) the ethanol extract of Solena heterophylla Lour (Sh.Cr) and (b) verapamil on concentration response curves of Ca2+ in
isolated rabbit jejunum preparations. Values are the mean ± SEM, n = 5.
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Figure 4 Concentration dependent inhibitory effect of (a, b and c) the ethanol extract of Solena heterophylla (Sh.Cr) and (d) dicyclomine on
carbachol (1 μM)- and high K+ (80 mM)- induced contractions in isolated rabbit tracheal preparations. Values are the mean ± SEM, n = 5.
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tanical therapies are still considered as safe by indigen-
ous communities to treat such ailments in developing
countries. The current study is aimed to rationalize the
folk use of a medicinal plant to cure these ailments. The
spasmolytic properties of Sh.Cr were evaluated by its
application to spontaneous contractions of isolated
rabbit jejunum preparation because these spontaneous
rhythmic contractions are suitable for direct testing of
relaxant activity without using any agonist [21]. The
Sh.Cr exhibited relaxant activity on rhythmic contrac-
tions in isolated rabbit jejunum preparations, thus dem-
onstrating its antispasmodic potential.
The contractile activities in smooth muscle prepara-
tions are function of increase/decrease in free Ca2+ con-
centration within cytoplasm [29] and the cellular free
Ca2+ concentration is increased by influx on either via
voltage dependent Ca2+ channels (VDCs) or release of
Ca2+ from sarcoplasmic stores [30]. Morevoer, the spon-
taneous rhythmic contractions in isolated rabbit jejunum
preparations are outcome of periodic depolarization sub-
sequent to repolarization, permitting a rapid influx of
Ca2+ through VDCs at the peak of depolarization [31].The observed spasmolytic effect of Sh.Cr is likely to
be attributed to a decrease in cytoplasmic Ca2+ due
to the blockade of VDCs or opening of K+ channels.
The sustained contractions in isolated rabbit jejunum
preparations subsequent to K+(25 mM) exposure
were not relaxed on treatment with Sh.Cr, indicating
that the spasmolytic activity of Sh.Cr was independ-
ent of K+-channels. However, K+(80 mM)-induced
contractions in isolated rabbit jejunum were found to
be relaxed following the treatment with Sh.Cr, indi-
cating that the spasmolytic effect may due to the
blockade of rapid influx of extracellular Ca2+ through
opened VDCs [24,32]. These findings agree with pre-
vious studies on medicinal plants [17,33]. These con-
siderations were further confirmed as the previous
treatment of isolated rabbit jejunum preparation with
Sh.Cr caused decrease in contractile response to Ca2+
and rightward shifting of the concentration response
curves for Ca2+ in a manner similar to verapamil, a
standard Ca2+ channel blocker [34]. The Ca2+ channel
blockers are an established class of therapeutic agents
and are known to be effective in hyperactive diseases of
the gut [35].
Figure 5 Effect of Sh.Cr on isolated rabbit aorta preparations. (a) Unstimulated aortic tissue as control. Concentration dependant inhibitory effect
of (b,c and d) ethanol extract of Solena heterophylla (Sh.Cr) and (e) verapamil on phenylephrine (1 μM)- and high K + (80 mM)- induced
contractions in isolated rabbit aorta preparations. Values are the mean ± SEM, n = 5.
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K+(80 mM)-induced contractions in isolated rabbit tra-
cheal preparations in a manner comparable to dicyclo-
mine and is mediated possibly through antagonism of
muscarinic receptors as well as the blockade of Ca2+
channels. The anti-muscarinic agents as well as Ca2+
channel blockers are useful bronchodilator in conditions
of increased sensitivity of the airway [30,31,36,37]. This
study provided a scientific basis to validate the traditional
uses of the plant in the management of respiratory disor-
ders including asthma, cough, and bronchitis.
The Sh.Cr exerted relaxant effect on phenylephrine
(1 μM)- and K+(80 mM)-induced contractions in iso-
lated rabbit aorta preparations, but phenylephrine-
induced contractions were relaxed at increased tissue
bath concentrations, indicating that the observed relax-
ant effect may possibly be mediated through the block-
ade of voltage dependent Ca2+ channel [32,38]. The
relaxant effect on isolated rabbit aorta preparations may
provide a scientific basis to validate the use of Solena
heterophylla in the management of hypertension.Conclusions
The observed relaxant effect may be outcome of anti-
muscarinic and Ca2+ channel blocking activities. The
Solena heterophylla exerted a relaxant effect against phe-
nyephrine (1 μM)- and K+(80 mM)-induced contractions
in isolated rabbit aortic preparations, possibly through
Ca2+ channel blocking activity. These findings provide a
rationale for the folkloric uses of the plant in the man-
agement of ailments pertaining to gastrointestinal, re-
spiratory and vascular system. However, more detailed
studies are required to establish the safety, efficacy
and toxicity of this plant and to isolate the bioactive
constituents.
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